ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Activin Receptor Type 1 Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22M7001
Home | Market Reports | Health| Pharmacy
Global Activin Receptor Type 1 Market Insights Forecast to 2028
BUY CHAPTERS

Global Activin Receptor Type 1 Market Research Report 2025

Code: QYRE-Auto-22M7001
Report
September 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Blueprint Medicines Corp
Daiichi Sankyo Company Ltd
La Jolla Pharmaceutical Company
Oncodesign SA
Tolero Pharmaceuticals Inc

Activin Receptor Type 1 Market

The global market for Activin Receptor Type 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Activin Receptor Type 1 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Activin Receptor Type 1 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Activin Receptor Type 1 include Blueprint Medicines Corp, Daiichi Sankyo Company Ltd, La Jolla Pharmaceutical Company, Oncodesign SA, Tolero Pharmaceuticals Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Activin Receptor Type 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activin Receptor Type 1.
The Activin Receptor Type 1 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Activin Receptor Type 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Activin Receptor Type 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Activin Receptor Type 1 Market Report

Report Metric Details
Report Name Activin Receptor Type 1 Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Blueprint Medicines Corp, Daiichi Sankyo Company Ltd, La Jolla Pharmaceutical Company, Oncodesign SA, Tolero Pharmaceuticals Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Activin Receptor Type 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Activin Receptor Type 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Activin Receptor Type 1 Market report?

Ans: The main players in the Activin Receptor Type 1 Market are Blueprint Medicines Corp, Daiichi Sankyo Company Ltd, La Jolla Pharmaceutical Company, Oncodesign SA, Tolero Pharmaceuticals Inc

What are the Application segmentation covered in the Activin Receptor Type 1 Market report?

Ans: The Applications covered in the Activin Receptor Type 1 Market report are Alport Syndrome, Chronic Kidney Disease, Kidney Fibrosis, Obesity, Others

What are the Type segmentation covered in the Activin Receptor Type 1 Market report?

Ans: The Types covered in the Activin Receptor Type 1 Market report are LJPC-6417, TP-0184, Dipyridamole, Others

Recommended Reports

Receptor Therapy Markets

Disease Therapies

Diagnostics & Devices

1 Activin Receptor Type 1 Market Overview
1.1 Product Definition
1.2 Activin Receptor Type 1 by Type
1.2.1 Global Activin Receptor Type 1 Market Value Comparison by Type (2024 VS 2031)
1.2.2 LJPC-6417
1.2.3 TP-0184
1.2.4 Dipyridamole
1.2.5 Others
1.3 Activin Receptor Type 1 by Application
1.3.1 Global Activin Receptor Type 1 Market Value by Application (2024 VS 2031)
1.3.2 Alport Syndrome
1.3.3 Chronic Kidney Disease
1.3.4 Kidney Fibrosis
1.3.5 Obesity
1.3.6 Others
1.4 Global Activin Receptor Type 1 Market Size Estimates and Forecasts
1.4.1 Global Activin Receptor Type 1 Revenue 2020-2031
1.4.2 Global Activin Receptor Type 1 Sales 2020-2031
1.4.3 Global Activin Receptor Type 1 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Activin Receptor Type 1 Market Competition by Manufacturers
2.1 Global Activin Receptor Type 1 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Activin Receptor Type 1 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Activin Receptor Type 1 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Activin Receptor Type 1, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Activin Receptor Type 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Activin Receptor Type 1, Product Type & Application
2.7 Global Key Manufacturers of Activin Receptor Type 1, Date of Enter into This Industry
2.8 Global Activin Receptor Type 1 Market Competitive Situation and Trends
2.8.1 Global Activin Receptor Type 1 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Activin Receptor Type 1 Players Market Share by Revenue
2.8.3 Global Activin Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Activin Receptor Type 1 Market Scenario by Region
3.1 Global Activin Receptor Type 1 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Activin Receptor Type 1 Sales by Region: 2020-2031
3.2.1 Global Activin Receptor Type 1 Sales by Region: 2020-2025
3.2.2 Global Activin Receptor Type 1 Sales by Region: 2026-2031
3.3 Global Activin Receptor Type 1 Revenue by Region: 2020-2031
3.3.1 Global Activin Receptor Type 1 Revenue by Region: 2020-2025
3.3.2 Global Activin Receptor Type 1 Revenue by Region: 2026-2031
3.4 North America Activin Receptor Type 1 Market Facts & Figures by Country
3.4.1 North America Activin Receptor Type 1 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Activin Receptor Type 1 Sales by Country (2020-2031)
3.4.3 North America Activin Receptor Type 1 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Activin Receptor Type 1 Market Facts & Figures by Country
3.5.1 Europe Activin Receptor Type 1 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Activin Receptor Type 1 Sales by Country (2020-2031)
3.5.3 Europe Activin Receptor Type 1 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Activin Receptor Type 1 Market Facts & Figures by Region
3.6.1 Asia Pacific Activin Receptor Type 1 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Activin Receptor Type 1 Sales by Region (2020-2031)
3.6.3 Asia Pacific Activin Receptor Type 1 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Activin Receptor Type 1 Market Facts & Figures by Country
3.7.1 Latin America Activin Receptor Type 1 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Activin Receptor Type 1 Sales by Country (2020-2031)
3.7.3 Latin America Activin Receptor Type 1 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Activin Receptor Type 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Activin Receptor Type 1 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Activin Receptor Type 1 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Activin Receptor Type 1 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Activin Receptor Type 1 Sales by Type (2020-2031)
4.1.1 Global Activin Receptor Type 1 Sales by Type (2020-2025)
4.1.2 Global Activin Receptor Type 1 Sales by Type (2026-2031)
4.1.3 Global Activin Receptor Type 1 Sales Market Share by Type (2020-2031)
4.2 Global Activin Receptor Type 1 Revenue by Type (2020-2031)
4.2.1 Global Activin Receptor Type 1 Revenue by Type (2020-2025)
4.2.2 Global Activin Receptor Type 1 Revenue by Type (2026-2031)
4.2.3 Global Activin Receptor Type 1 Revenue Market Share by Type (2020-2031)
4.3 Global Activin Receptor Type 1 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Activin Receptor Type 1 Sales by Application (2020-2031)
5.1.1 Global Activin Receptor Type 1 Sales by Application (2020-2025)
5.1.2 Global Activin Receptor Type 1 Sales by Application (2026-2031)
5.1.3 Global Activin Receptor Type 1 Sales Market Share by Application (2020-2031)
5.2 Global Activin Receptor Type 1 Revenue by Application (2020-2031)
5.2.1 Global Activin Receptor Type 1 Revenue by Application (2020-2025)
5.2.2 Global Activin Receptor Type 1 Revenue by Application (2026-2031)
5.2.3 Global Activin Receptor Type 1 Revenue Market Share by Application (2020-2031)
5.3 Global Activin Receptor Type 1 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Blueprint Medicines Corp
6.1.1 Blueprint Medicines Corp Company Information
6.1.2 Blueprint Medicines Corp Description and Business Overview
6.1.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Blueprint Medicines Corp Activin Receptor Type 1 Product Portfolio
6.1.5 Blueprint Medicines Corp Recent Developments/Updates
6.2 Daiichi Sankyo Company Ltd
6.2.1 Daiichi Sankyo Company Ltd Company Information
6.2.2 Daiichi Sankyo Company Ltd Description and Business Overview
6.2.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product Portfolio
6.2.5 Daiichi Sankyo Company Ltd Recent Developments/Updates
6.3 La Jolla Pharmaceutical Company
6.3.1 La Jolla Pharmaceutical Company Company Information
6.3.2 La Jolla Pharmaceutical Company Description and Business Overview
6.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product Portfolio
6.3.5 La Jolla Pharmaceutical Company Recent Developments/Updates
6.4 Oncodesign SA
6.4.1 Oncodesign SA Company Information
6.4.2 Oncodesign SA Description and Business Overview
6.4.3 Oncodesign SA Activin Receptor Type 1 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Oncodesign SA Activin Receptor Type 1 Product Portfolio
6.4.5 Oncodesign SA Recent Developments/Updates
6.5 Tolero Pharmaceuticals Inc
6.5.1 Tolero Pharmaceuticals Inc Company Information
6.5.2 Tolero Pharmaceuticals Inc Description and Business Overview
6.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product Portfolio
6.5.5 Tolero Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Activin Receptor Type 1 Industry Chain Analysis
7.2 Activin Receptor Type 1 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Activin Receptor Type 1 Production Mode & Process Analysis
7.4 Activin Receptor Type 1 Sales and Marketing
7.4.1 Activin Receptor Type 1 Sales Channels
7.4.2 Activin Receptor Type 1 Distributors
7.5 Activin Receptor Type 1 Customer Analysis
8 Activin Receptor Type 1 Market Dynamics
8.1 Activin Receptor Type 1 Industry Trends
8.2 Activin Receptor Type 1 Market Drivers
8.3 Activin Receptor Type 1 Market Challenges
8.4 Activin Receptor Type 1 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Blueprint Medicines Corp
Daiichi Sankyo Company Ltd
La Jolla Pharmaceutical Company
Oncodesign SA
Tolero Pharmaceuticals Inc
List of Tables
 Table 1. Global Activin Receptor Type 1 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Activin Receptor Type 1 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Activin Receptor Type 1 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Activin Receptor Type 1 Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Activin Receptor Type 1 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Activin Receptor Type 1 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Activin Receptor Type 1 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Activin Receptor Type 1 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Activin Receptor Type 1, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Activin Receptor Type 1, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Activin Receptor Type 1, Product Type & Application
 Table 12. Global Key Manufacturers of Activin Receptor Type 1, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Activin Receptor Type 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activin Receptor Type 1 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Activin Receptor Type 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Activin Receptor Type 1 Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Activin Receptor Type 1 Sales Market Share by Region (2020-2025)
 Table 19. Global Activin Receptor Type 1 Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Activin Receptor Type 1 Sales Market Share by Region (2026-2031)
 Table 21. Global Activin Receptor Type 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Activin Receptor Type 1 Revenue Market Share by Region (2020-2025)
 Table 23. Global Activin Receptor Type 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Activin Receptor Type 1 Revenue Market Share by Region (2026-2031)
 Table 25. North America Activin Receptor Type 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Activin Receptor Type 1 Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Activin Receptor Type 1 Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Activin Receptor Type 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Activin Receptor Type 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Activin Receptor Type 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Activin Receptor Type 1 Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Activin Receptor Type 1 Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Activin Receptor Type 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Activin Receptor Type 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Activin Receptor Type 1 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Activin Receptor Type 1 Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Activin Receptor Type 1 Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Activin Receptor Type 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Activin Receptor Type 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Activin Receptor Type 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Activin Receptor Type 1 Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Activin Receptor Type 1 Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Activin Receptor Type 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Activin Receptor Type 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Activin Receptor Type 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Activin Receptor Type 1 Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Activin Receptor Type 1 Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Activin Receptor Type 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Activin Receptor Type 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Activin Receptor Type 1 Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Activin Receptor Type 1 Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Activin Receptor Type 1 Sales Market Share by Type (2020-2025)
 Table 53. Global Activin Receptor Type 1 Sales Market Share by Type (2026-2031)
 Table 54. Global Activin Receptor Type 1 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Activin Receptor Type 1 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Activin Receptor Type 1 Revenue Market Share by Type (2020-2025)
 Table 57. Global Activin Receptor Type 1 Revenue Market Share by Type (2026-2031)
 Table 58. Global Activin Receptor Type 1 Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Activin Receptor Type 1 Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Activin Receptor Type 1 Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Activin Receptor Type 1 Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Activin Receptor Type 1 Sales Market Share by Application (2020-2025)
 Table 63. Global Activin Receptor Type 1 Sales Market Share by Application (2026-2031)
 Table 64. Global Activin Receptor Type 1 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Activin Receptor Type 1 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Activin Receptor Type 1 Revenue Market Share by Application (2020-2025)
 Table 67. Global Activin Receptor Type 1 Revenue Market Share by Application (2026-2031)
 Table 68. Global Activin Receptor Type 1 Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Activin Receptor Type 1 Price (USD/Pcs) by Application (2026-2031)
 Table 70. Blueprint Medicines Corp Company Information
 Table 71. Blueprint Medicines Corp Description and Business Overview
 Table 72. Blueprint Medicines Corp Activin Receptor Type 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Blueprint Medicines Corp Activin Receptor Type 1 Product
 Table 74. Blueprint Medicines Corp Recent Developments/Updates
 Table 75. Daiichi Sankyo Company Ltd Company Information
 Table 76. Daiichi Sankyo Company Ltd Description and Business Overview
 Table 77. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product
 Table 79. Daiichi Sankyo Company Ltd Recent Developments/Updates
 Table 80. La Jolla Pharmaceutical Company Company Information
 Table 81. La Jolla Pharmaceutical Company Description and Business Overview
 Table 82. La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. La Jolla Pharmaceutical Company Activin Receptor Type 1 Product
 Table 84. La Jolla Pharmaceutical Company Recent Developments/Updates
 Table 85. Oncodesign SA Company Information
 Table 86. Oncodesign SA Description and Business Overview
 Table 87. Oncodesign SA Activin Receptor Type 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Oncodesign SA Activin Receptor Type 1 Product
 Table 89. Oncodesign SA Recent Developments/Updates
 Table 90. Tolero Pharmaceuticals Inc Company Information
 Table 91. Tolero Pharmaceuticals Inc Description and Business Overview
 Table 92. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product
 Table 94. Tolero Pharmaceuticals Inc Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Activin Receptor Type 1 Distributors List
 Table 98. Activin Receptor Type 1 Customers List
 Table 99. Activin Receptor Type 1 Market Trends
 Table 100. Activin Receptor Type 1 Market Drivers
 Table 101. Activin Receptor Type 1 Market Challenges
 Table 102. Activin Receptor Type 1 Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Activin Receptor Type 1
 Figure 2. Global Activin Receptor Type 1 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Activin Receptor Type 1 Market Share by Type: 2024 & 2031
 Figure 4. LJPC-6417 Product Picture
 Figure 5. TP-0184 Product Picture
 Figure 6. Dipyridamole Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Activin Receptor Type 1 Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Activin Receptor Type 1 Market Share by Application: 2024 & 2031
 Figure 10. Alport Syndrome
 Figure 11. Chronic Kidney Disease
 Figure 12. Kidney Fibrosis
 Figure 13. Obesity
 Figure 14. Others
 Figure 15. Global Activin Receptor Type 1 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Activin Receptor Type 1 Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Activin Receptor Type 1 Sales (2020-2031) & (K Pcs)
 Figure 18. Global Activin Receptor Type 1 Average Price (USD/Pcs) & (2020-2031)
 Figure 19. Activin Receptor Type 1 Report Years Considered
 Figure 20. Activin Receptor Type 1 Sales Share by Manufacturers in 2024
 Figure 21. Global Activin Receptor Type 1 Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Activin Receptor Type 1 Players: Market Share by Revenue in Activin Receptor Type 1 in 2024
 Figure 23. Activin Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Activin Receptor Type 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Activin Receptor Type 1 Sales Market Share by Country (2020-2031)
 Figure 26. North America Activin Receptor Type 1 Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Activin Receptor Type 1 Sales Market Share by Country (2020-2031)
 Figure 30. Europe Activin Receptor Type 1 Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Activin Receptor Type 1 Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Activin Receptor Type 1 Revenue Market Share by Region (2020-2031)
 Figure 38. China Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Activin Receptor Type 1 Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Activin Receptor Type 1 Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Activin Receptor Type 1 Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Activin Receptor Type 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Activin Receptor Type 1 by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Activin Receptor Type 1 by Type (2020-2031)
 Figure 60. Global Activin Receptor Type 1 Price (USD/Pcs) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Activin Receptor Type 1 by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Activin Receptor Type 1 by Application (2020-2031)
 Figure 63. Global Activin Receptor Type 1 Price (USD/Pcs) by Application (2020-2031)
 Figure 64. Activin Receptor Type 1 Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Activin Market Research Report 2024
Global Activin and Inhibin Market Research Report 2024
Global Insulin Like Growth Factor 1 Receptor Market Research Report 2024
Global Endo Activator Market Research Report 2024
Global Vasopressin V1b Receptor Market Research Report 2025
Global Growth Hormone Secretagogue Receptor Type 1 Market Research Report 2024
Global Somatostatin Receptor Type 4 Market Research Report 2024
Global Fibroblast Growth Factor Receptor 2 Market Research Report 2025
Global Estrogen Receptor Market Research Report 2024
Global Retinoic Acid Receptor Alpha Market Research Report 2024
Global Retinoic Acid Receptor Gamma Market Research Report 2024
Global Retinoic Acid Receptor Beta Market Research Report 2024
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Research Report 2024
Global Angiopoietin 1 Receptor Market Research Report 2024
Global Leptin Receptor Market Research Report 2024
Global Progesterone Receptor Agonist Market Research Report 2024
Global Metabotropic Glutamate Receptor 1 Market Research Report 2025
Global Tachykinin Receptor 1 Antibody Market Research Report 2024
Global Androgen Receptor AR Inhibitor Market Research Report 2025
Global GCG Receptor Agonist Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions